Dr. Mitchell G. Miglis, MD
Neurology (Clinical Neurophysiology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Florida College of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 395
Licensed in California since 2012, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: University of Florida College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Neurophysiology Physician primary
CA license A121294 (first issued 2012; current) -
Neurology Physician
CA license A121294 (first issued 2012; current) -
Sleep Medicine (Psychiatry & Neurology) Physician
CA license A121294 (first issued 2012; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 395
- Services billed
- 675
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 245 | 189 |
| Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | 64 | 64 |
| Established patient office or other outpatient visit, 40-54 minutes | 61 | 51 |
| Testing of autonomic (sympathetic) nervous system function | 55 | 55 |
| Sleep study in sleep lab (6 years or older) | 29 | 29 |
| Established patient office or other outpatient visit, 20-29 minutes | 25 | 24 |
| Sleep study including heart rate, breathing, and sleep time | 20 | 20 |
| New patient office or other outpatient visit, 60-74 minutes | 15 | 15 |
| Sleep study in sleep lab | 13 | 12 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Stanford, CA | 114 |
| Droxidopa | 83 |
| Midodrine Hcl Other prescribers in Stanford, CA | 80 |
| Modafinil Other prescribers in Stanford, CA | 70 |
| Clonazepam Other prescribers in Stanford, CA | 61 |
| Pyridostigmine Bromide Other prescribers in Stanford, CA | 45 |
| Fludrocortisone Acetate Other prescribers in Stanford, CA | 39 |
| Pramipexole Dihydrochloride (pramipexole di-hcl) Other prescribers in Stanford, CA | 36 |
| Belsomra (suvorexant) Other prescribers in Stanford, CA | 35 |
| Carbamazepine Other prescribers in Stanford, CA | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 30 payments worth $21,981 in total to this clinician.
| Jazz Pharmaceuticals Inc. | $18,646 |
|---|---|
| Lundbeck LLC | $3,200 |
| Harmony Biosciences LLC | $135 |
| Consulting Fee | $16,452 |
|---|---|
| Honoraria | $3,200 |
| Food and Beverage | $1,375 |
| Travel and Lodging | $954 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Consulting Fee XYWAV · NEUROLOGY | $13,338 |
| Lundbeck LLC Dec 23, 2025 | Honoraria | $3,200 |
| Jazz Pharmaceuticals Inc. May 30, 2025 | Consulting Fee XYWAV · NEUROLOGY | $2,223 |
| Jazz Pharmaceuticals Inc. Nov 17, 2025 | Consulting Fee | $741 |
| Jazz Pharmaceuticals Inc. Jun 5, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Seattle, WA · in-kind | $368 |
| Jazz Pharmaceuticals Inc. Jun 5, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Seattle, WA · in-kind | $341 |
| Jazz Pharmaceuticals Inc. Jan 16, 2025 | Consulting Fee XYWAV; XYREM · NEUROLOGY | $150 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $63.10 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $57.60 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $47.91 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Lundbeck LLC Dec 23, 2025 | Honoraria | $3,200 |
| Jazz Pharmaceuticals Inc. Nov 17, 2025 | Consulting Fee | $741 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Consulting Fee XYWAV · NEUROLOGY | $13,338 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $63.10 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $57.60 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $47.91 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $40.90 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to San Francisco, CA · in-kind | $19.98 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Seattle, WA · in-kind | $8.00 |
| Jazz Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Redwood City, CA · in-kind | $7.93 |
| Jazz Pharmaceuticals Inc. Jun 5, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Seattle, WA · in-kind | $368 |
| Jazz Pharmaceuticals Inc. Jun 5, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Seattle, WA · in-kind | $341 |
| Jazz Pharmaceuticals Inc. May 30, 2025 | Consulting Fee XYWAV · NEUROLOGY | $2,223 |
| Jazz Pharmaceuticals Inc. Jan 16, 2025 | Consulting Fee XYWAV; XYREM · NEUROLOGY | $150 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $132,532 in research payments for these studies, mostly to the institutions running them.
- Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Regeneron Pharmaceuticals, Inc. · Completed · NCT06593600 - Quincy Model - Open-Label Extension Study to Evaluate the Long term Safety and Efficacy of Efgartigimod in Adult Patients with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) who Completed Study ARGX…
Argenx US, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.